Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor–Positive, Early Breast Cancer

BACKGROUND: EarlyR gene signature in estrogen receptor–positive (ER+) breast cancer is computed from the expression values of ESPL1, SPAG5, MKI67, PLK1, and PGR. EarlyR has been validated in multiple cohorts profiled using microarrays. This study sought to verify the prognostic features of EarlyR in...

Descripción completa

Detalles Bibliográficos
Autores principales: Buechler, Steven A, Gray, Kathryn P, Gökmen-Polar, Yesim, Willis, Scooter, Thürlimann, Beat, Kammler, Rosita, Viale, Giuseppe, Leyland-Jones, Brian, Badve, Sunil S, Regan, Meredith M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049990/
https://www.ncbi.nlm.nih.gov/pubmed/32337480
http://dx.doi.org/10.1093/jncics/pkz051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049990/
https://www.ncbi.nlm.nih.gov/pubmed/32337480
http://dx.doi.org/10.1093/jncics/pkz051

Ejemplares similares